AMR Conference Puts Focus on Research, Stewardship, Innovation and Diagnostics
Leading infectious diseases experts highlighted issues critical to confronting, controlling and reversing the growing global public health threat of pathogens that are increasingly unresponsive to existing treatments, at the recent World Antimicrobial Resistance Congress in Washington, DC.
With more than 400 health providers, regulators, funders, researchers, investors and industry as well as health policy leaders in attendance, the conference examined urgent needs, challenges and solutions for antibiotic research and development, antimicrobial stewardship, rapid diagnostic technologies, and collaborative partnerships.
Want to learn more about what IDSA is doing to promote antimicrobial stewardship in health care? Watch this video!
Paul Auwaerter, MD, FIDSA, Immediate Past President of IDSA, discussed the need to invest in the clinical, research and public health workforce to ensure comprehensive responses to antimicrobial resistance in a keynote address “The Other Pipeline Problem: Where are the AMR Experts?”
IDSA Senior Vice President for Public Policy and Government Relations, Amanda Jezek, led a discussion on working with policymakers on antimicrobial resistance solutions, and also participated in a panel examining “pull” incentives for antibiotic research and development. The group discussed stewardship, rapid diagnosis and early treatment of infections, and clinical trial designs in the development of new diagnostics.